Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32362299.
- Also identified by DOI 10.1192/bjp.2020.92 and PMC identifier 7248582.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
Medical subject headings
- Anxiety
- Coronavirus Infections
- Mental Disorders
- Pandemics
- Pneumonia, Viral
- Practice Patterns, Physicians'
- Psychotherapy
- Psychotropic Drugs